{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:32:40Z","timestamp":1770723160183,"version":"3.49.0"},"posted":{"date-parts":[[2026,2,5]]},"group-title":"Microbiology","reference-count":74,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>The primary route of HIV transmission is across mucosal tissues; therefore, developing a protective mucosal vaccine is a top priority. In a pilot study, using a macaque model, we delivered HIV gp140 envelope glycoprotein and SIVmac239 P55 Gag and Nef antigens using heterologous prime\/boost via the intranasal route with a soybean oil-based nanoemulsion (NE) adjuvant and through the intramuscular route with the AS01B adjuvant system to generate enhanced cell-mediated immunity. We used a NE adjuvant to promote gut-homing cell-mediated immunity and the AS01B system to enhance humoral immune responses. Following intrarectal challenge with SHIV 4MTF.tHy, vaccinated macaques acquired the virus but experienced lower viral loads in plasma (P=0.003) and CSF (P=0.001), and potent polyfunctional gag-specific (CD107a+, IFN\u03b3, TNF\u03b1+) responses across diverse lymph nodes. Significant antibody-dependent complement deposition (ADCD) and antibody-dependent cellular phagocytosis (ADCP) responses were induced, and gut-microbiome crosstalk could be modulated and showing reduced SHIV-dysbiosis. Notably, vaccination preserved mucosal all-trans retinoic acid levels (atRA) (p&lt;0.05). However, no significant differences were observed for antibody responses between vaccinated and unvaccinated macaques. In summary, the induced gut-homing properties by the NE adjuvant are effective at generating cell-mediated immunity and reducing viral set points and warrant further investigations as a mucosal adjuvant in HIV vaccine design.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Three major non-mucosal vaccine trials (RV144, HVTN702, and 706) failed to reduce HIV infection rates. Therefore, new approaches in developing a mucosal vaccine remain an effective strategy to attempt to control HIV infection. Coherent vaccine approaches against HIV were focused on immune correlates related to viral loads, persistent reservoirs, and antibody responses. As a proof-of-principle, we developed a vaccine regimen consisting of AS01B and an adjuvanted oil-in-water NE cleaved HIV clade C gp140 protein and non-cleaved Gag, and nef particles administered through intranasal, subcutaneous, and intramuscular routes, followed by intrarectal challenge with clade C SHIV. This vaccine elicited strong ADCD and ADCP responses, modulated immune-microbiome crosstalk, and reduced susceptibility to SHIV-infection-associated dysbiosis. Additionally, it preserved mucosal all trans retinoic acid (atRA) levels, suggesting a potential role for this approach in HIV vaccine development.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.02.04.703720","type":"posted-content","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:05:20Z","timestamp":1770318320000},"source":"Crossref","is-referenced-by-count":0,"title":["Intranasal Delivery of HIV\/SIV Antigens with NE\/AS01B Adjuvants Enhances Cellular Immunity and Reduces Viral Loads in SHIV-Challenged Macaques"],"prefix":"10.64898","author":[{"given":"Michellie","family":"Thurman","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanathan","family":"Chokkavelu","sequence":"additional","affiliation":[{"name":"Clinical Infectious Unit, Fort Myers, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel D.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omalla A","family":"Olwenyi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokul Raj","family":"Kathamuthu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianshi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson","family":"Adeniji","sequence":"additional","affiliation":[{"name":"The Wistar Institute, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai Ying","family":"Hong","sequence":"additional","affiliation":[{"name":"The Wistar Institute, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepanwita","family":"Bose","sequence":"additional","affiliation":[{"name":"New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA 70560, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabita","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-3952","authenticated-orcid":false,"given":"Xiaoying","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-6319","authenticated-orcid":false,"given":"David","family":"Montefiori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela T.","family":"Wong","sequence":"additional","affiliation":[{"name":"Michigan Nanotechnology Institute, for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arber, MI, USA"},{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Mary H Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"James R","family":"Baker","sequence":"additional","affiliation":[{"name":"Michigan Nanotechnology Institute, for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arber, MI, USA"},{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Mary H Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7790-2008","authenticated-orcid":false,"given":"Francois","family":"Villinger","sequence":"additional","affiliation":[{"name":"New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA 70560, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5525-9170","authenticated-orcid":false,"given":"Maureen","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[{"name":"The Wistar Institute, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-4640","authenticated-orcid":false,"given":"Siddappa N.","family":"Byrareddy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026020907150878000_2026.02.04.703720v1.1","unstructured":"https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids. The global health observatory 2023."},{"key":"2026020907150878000_2026.02.04.703720v1.2","doi-asserted-by":"crossref","unstructured":"Casper C , Crane H , Menon M , Money D. 2018. HIV\/AIDS comorbidities: impact on cancer, noncommunicable diseases, and reproductive health.","DOI":"10.1596\/978-1-4648-0524-0_ch3"},{"key":"2026020907150878000_2026.02.04.703720v1.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583934"},{"key":"2026020907150878000_2026.02.04.703720v1.4","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2014.945601"},{"key":"2026020907150878000_2026.02.04.703720v1.5","first-page":"e0186638","article-title":"Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the USA: a modelling study","volume":"23:12","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"2026020907150878000_2026.02.04.703720v1.6","first-page":"e02834","article-title":"HIV-1 Is a Poor Inducer of Innate Immune Responses","volume":"10","year":"2019","journal-title":"mBio"},{"key":"2026020907150878000_2026.02.04.703720v1.7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/vaccines9030271","article-title":"The Importance of Regulation in Natural Immunity to HIV","volume":"9","year":"2021","journal-title":"Vaccines (Basel"},{"key":"2026020907150878000_2026.02.04.703720v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.10.015"},{"key":"2026020907150878000_2026.02.04.703720v1.9","doi-asserted-by":"crossref","first-page":"590780","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions","volume":"11","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"2026020907150878000_2026.02.04.703720v1.10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2020.04.008","article-title":"Therapeutic Vaccines for the Treatment of HIV","volume":"223","year":"2020","journal-title":"Translational Research"},{"key":"2026020907150878000_2026.02.04.703720v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908492"},{"key":"2026020907150878000_2026.02.04.703720v1.12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMe2102358","article-title":"Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"2026020907150878000_2026.02.04.703720v1.13","doi-asserted-by":"publisher","DOI":"10.1080\/08830180802684331"},{"key":"2026020907150878000_2026.02.04.703720v1.14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130254"},{"key":"2026020907150878000_2026.02.04.703720v1.15","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31827146e0"},{"key":"2026020907150878000_2026.02.04.703720v1.16","doi-asserted-by":"publisher","DOI":"10.1086\/503258"},{"key":"2026020907150878000_2026.02.04.703720v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61591-3"},{"key":"2026020907150878000_2026.02.04.703720v1.18","first-page":"e01844","article-title":"Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5\u03b1 Restrictive Macaques","volume":"91","year":"2017","journal-title":"J Virol"},{"key":"2026020907150878000_2026.02.04.703720v1.19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1573395514666180605092054","article-title":"Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission","volume":"15","year":"2019","journal-title":"Curr Immunol Rev"},{"key":"2026020907150878000_2026.02.04.703720v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003038"},{"key":"2026020907150878000_2026.02.04.703720v1.21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01796-17"},{"key":"2026020907150878000_2026.02.04.703720v1.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003618"},{"key":"2026020907150878000_2026.02.04.703720v1.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314351110"},{"key":"2026020907150878000_2026.02.04.703720v1.24","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1181236"},{"key":"2026020907150878000_2026.02.04.703720v1.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126120"},{"key":"2026020907150878000_2026.02.04.703720v1.26","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2007.0148"},{"key":"2026020907150878000_2026.02.04.703720v1.27","doi-asserted-by":"crossref","unstructured":"Cunningham AL , Heineman TC , Lal H , Godeaux O , Chlibek R , Hwang SJ , McElhaney JE , Vesikari T , Andrews C , Choi WS , Esen M , Ikematsu H , Choma MK , Pauksens K , Ravault S , Salaun B , Schwarz TF , Smetana J , Abeele CV , Van den Steen P , Vastiau I , Weckx LY , Levin MJ, ZOE-50\/70 Study Group . Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. J Infect Dis 217: 1750\u20131760.","DOI":"10.1093\/infdis\/jiy095"},{"key":"2026020907150878000_2026.02.04.703720v1.28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":". Recombinant Zoster Vaccine (Shingrix(\u00ae)): A Review in Herpes Zoster","volume":"35","year":"2018","journal-title":"Drugs Aging"},{"key":"2026020907150878000_2026.02.04.703720v1.29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041196"},{"key":"2026020907150878000_2026.02.04.703720v1.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000852"},{"key":"2026020907150878000_2026.02.04.703720v1.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003829"},{"key":"2026020907150878000_2026.02.04.703720v1.32","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1002\/ctd2.58","article-title":"HIV-associated dysbiosis and immune recovery during antiretroviral therapy","volume":"2","year":"2022","journal-title":"Clinical and Translational Discovery"},{"issue":"6","key":"2026020907150878000_2026.02.04.703720v1.33","doi-asserted-by":"crossref","first-page":"e184491","DOI":"10.1172\/jci.insight.184491","article-title":"IL-21 and anti-\u03b14\u03b27 dual therapy during ART promotes immunological and microbiome responses in SIV-infected macaques","volume":"10","year":"2025","journal-title":"JCI Insight"},{"key":"2026020907150878000_2026.02.04.703720v1.34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/mi.2015.75","article-title":"IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques","volume":"9","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2026020907150878000_2026.02.04.703720v1.35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41467-021-21472-1","article-title":"Fecal microbiota transplantation in HIV: A pilot placebo-controlled study","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"2026020907150878000_2026.02.04.703720v1.36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/HP.0000000000001477","article-title":"Effect of Radiation on the Essential Nutrient Homeostasis and Signaling of Retinoids in a Non-human Primate Model with Minimal Bone Marrow Sparing","volume":"121","year":"2021","journal-title":"Health physics"},{"key":"2026020907150878000_2026.02.04.703720v1.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag1276"},{"issue":"1","key":"2026020907150878000_2026.02.04.703720v1.38","doi-asserted-by":"crossref","first-page":"2315224","DOI":"10.1080\/07853890.2024.2315224","article-title":"Dual role for microbial short-chain fatty acids in modifying SIV disease trajectory following anti-\u03b14\u03b27 antibody administration","volume":"56","year":"2024","journal-title":"Ann Med"},{"key":"2026020907150878000_2026.02.04.703720v1.39","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fimmu.2019.00916","article-title":"Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway","volume":"10","year":"2019","journal-title":"Front Immunol"},{"key":"2026020907150878000_2026.02.04.703720v1.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.04.010"},{"key":"2026020907150878000_2026.02.04.703720v1.41","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001366"},{"key":"2026020907150878000_2026.02.04.703720v1.42","doi-asserted-by":"crossref","unstructured":"de Jong SE , Olin A , Pulendran B . The Impact of the Microbiome on Immunity to Vaccination in Humans. Cell Host Microbe 28: 169\u2013179.","DOI":"10.1016\/j.chom.2020.06.014"},{"key":"2026020907150878000_2026.02.04.703720v1.43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323392"},{"key":"2026020907150878000_2026.02.04.703720v1.44","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fmicb.2020.01065","article-title":"The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages","volume":"11","year":"2020","journal-title":"Frontiers in microbiology"},{"key":"2026020907150878000_2026.02.04.703720v1.45","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071775"},{"key":"2026020907150878000_2026.02.04.703720v1.46","doi-asserted-by":"crossref","first-page":"103118","DOI":"10.1016\/j.ebiom.2020.103118","article-title":"Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies","volume":"62","year":"2020","journal-title":"EBioMedicine"},{"key":"2026020907150878000_2026.02.04.703720v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19970-3"},{"key":"2026020907150878000_2026.02.04.703720v1.48","doi-asserted-by":"publisher","DOI":"10.1086\/510909"},{"key":"2026020907150878000_2026.02.04.703720v1.49","doi-asserted-by":"crossref","first-page":"e0210965","DOI":"10.1371\/journal.pone.0210965","article-title":"Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption","volume":"14","year":"2019","journal-title":"PLoS One"},{"key":"2026020907150878000_2026.02.04.703720v1.50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054300"},{"key":"2026020907150878000_2026.02.04.703720v1.51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02634-13"},{"key":"2026020907150878000_2026.02.04.703720v1.52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02032-14"},{"key":"2026020907150878000_2026.02.04.703720v1.53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11684-019-0721-9","article-title":"Broadly neutralizing antibodies and vaccine design against HIV-1 infection","volume":"14","year":"2020","journal-title":"Front Med"},{"key":"2026020907150878000_2026.02.04.703720v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.030"},{"key":"2026020907150878000_2026.02.04.703720v1.55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00347-16"},{"key":"2026020907150878000_2026.02.04.703720v1.56","first-page":"e02325","article-title":"Monoclonal antibodies specific for the V2, V3, CD4-binding site, and gp41 of HIV-1 mediate phagocytosis in a dose-dependent manner","volume":"91","year":"2017","journal-title":"Journal of virology"},{"key":"2026020907150878000_2026.02.04.703720v1.57","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949351"},{"key":"2026020907150878000_2026.02.04.703720v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0782-y"},{"key":"2026020907150878000_2026.02.04.703720v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-019-0258-7"},{"key":"2026020907150878000_2026.02.04.703720v1.60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009101"},{"key":"2026020907150878000_2026.02.04.703720v1.61","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jaci.2018.01.042","article-title":"Nanoemulsion adjuvant-driven redirection of T(H)2 immunity inhibits allergic reactions in murine models of peanut allergy","volume":"141","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026020907150878000_2026.02.04.703720v1.62","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/IJN.S232677","article-title":"O\/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying","volume":"15","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"2026020907150878000_2026.02.04.703720v1.63","doi-asserted-by":"crossref","first-page":"1001727","DOI":"10.3389\/fimmu.2022.1001727","article-title":"Early treatment with anti-\u03b14\u03b27 antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques","volume":"13","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"2026020907150878000_2026.02.04.703720v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33950-6"},{"key":"2026020907150878000_2026.02.04.703720v1.65","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00054-05"},{"key":"2026020907150878000_2026.02.04.703720v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.86"},{"key":"2026020907150878000_2026.02.04.703720v1.67","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1099\/0022-1317-50-5-421","article-title":"Novel Helicobacter species isolated from rhesus monkeys with chronic idiopathic colitis","volume":"50","year":"2001","journal-title":"Journal of Medical Microbiology"},{"key":"2026020907150878000_2026.02.04.703720v1.68","first-page":"e0196942","article-title":"High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses","volume":"13","year":"2008","journal-title":"PLoS One"},{"key":"2026020907150878000_2026.02.04.703720v1.69","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02419-10"},{"key":"2026020907150878000_2026.02.04.703720v1.70","doi-asserted-by":"crossref","unstructured":"Fischinger S , Fallon JK , Michell AR , Broge T , Suscovich TJ , Streeck H , Alter G . A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation. J Immunol Methods 473: 112630.","DOI":"10.1016\/j.jim.2019.07.002"},{"key":"2026020907150878000_2026.02.04.703720v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2010.12.016"},{"key":"2026020907150878000_2026.02.04.703720v1.72","first-page":"1","article-title":"Quantification of endogenous retinoids. Methods in molecular biology (Clifton","volume":"652","year":"2010","journal-title":"N.J"},{"key":"2026020907150878000_2026.02.04.703720v1.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2008.03.038"},{"key":"2026020907150878000_2026.02.04.703720v1.74","doi-asserted-by":"publisher","DOI":"10.1021\/ac702030f"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.02.04.703720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:15:16Z","timestamp":1770650116000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.02.04.703720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":74,"URL":"https:\/\/doi.org\/10.64898\/2026.02.04.703720","relation":{},"subject":[],"published":{"date-parts":[[2026,2,5]]},"subtype":"preprint"}}